Abbott Laboratories (ABT)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

ABT logo

ABT Deferred Revenue

Latest reported$0.00
ABT Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

ABT deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232,000,000
261,000,000
430,000,000
483,000,000
589,000,000
534,000,000
270,000,000
481,000,000
181,000,000
152,000,000
175,000,000
228,175,000
138,772,000
141,978,000
655,424,000
709,364,000
477,459,000
759,361,000
514,947,000
466,855,000
487,376,000
1,272,280,000
1,307,723,000
874,915,000
906,674,000
769,488,000
442,140,000
1,184,353,000
932,321,000
926,513,000
6,592,515,000
5,689,270,000
0
5,232,601,000
3,713,104,000
5,013,204,000
4,494,364,000
4,580,195,000
3,850,723,000
4,467,810,000
4,379,182,000
3,647,906,000
0
0
0
0
0
0
0
0
2,180,098,000
0
0
0
2,202,477,000
0
0
0
2,285,644,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.